why choose us

First received: September 01, 2023

Clinical Trial: A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Arthritis, Rheumatoid

Study Type: INTERVENTIONAL


Official Title: A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of Concept Study Evaluating the Efficacy and Safety of Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rh

Brief Summary: The purpose of this study is to evaluate the efficacy of combination therapy with nipocalimab and certolizumab compared to certolizumab monotherapy.

Read more